Agios Pharmaceuticals
AGIO
#5134
Rank
ยฃ1.26 B
Marketcap
ยฃ21.08
Share price
-4.03%
Change (1 day)
23.23%
Change (1 year)

EPS for Agios Pharmaceuticals (AGIO)

EPS in 2026 (TTM): -ยฃ4.70

According to Agios Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ4.77. In 2021 the company made an earnings per share (EPS) of ยฃ16.98 an increase over its 2020 EPS that were of -ยฃ3.62.

EPS history for Agios Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ4.70
2021ยฃ16.98-569.2%
2020-ยฃ3.62-31%
2019-ยฃ5.2513.93%
2018-ยฃ4.60-10.53%
2017-ยฃ5.1533.47%
2016-ยฃ3.8661.34%
2015-ยฃ2.3998.1%
2014-ยฃ1.21-4.34%
2013-ยฃ1.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.54-111.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.59-594.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.20-146.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-ยฃ1.20-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ2.64-155.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-ยฃ0.06873-98.56%๐Ÿ‡บ๐Ÿ‡ธ USA